Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 April 2024 | Story Lunga Luthuli | Photo SUPPLIED
Dr Kamwendo
Dr Juliet Kamwendo champions gender-inclusive climate action in Africa. Her expertise at the recently held AFR100 workshop highlighted vital steps towards sustainable and equitable development.

Dr Juliet Kamwendo, Lecturer and Programme Director for Gender Studies in the Centre for Gender and Africa Studies at the University of the Free State, is spearheading efforts to integrate gender considerations into Africa's climate restoration agenda. Reflecting on her involvement, Dr Kamwendo stated, "This is particularly crucial, as women make up almost 50% of the population in Africa, and the depletion and degradation of land affect them disproportionately."

She recently served as a gender expert at the AUDA-NEPAD AFR100 workshop in Ouagadougou, Burkina Faso, from 25 to 29 March 2024. This initiative aims to restore forests and degraded land across Africa by 2030, with a focus on gender equality.

The workshop emphasised the integration of gender perspectives into the AFR100 project, acknowledging the disproportionate impact of land degradation on women. Dr Kamwendo's expertise highlighted the need to empower women in climate change interventions, addressing existing gender inequalities exacerbated by environmental degradation.

“Women – who are primarily responsible for household food security and water provision – bear the brunt of environmental degradation, leading to increased workloads, reduced income opportunities, and heightened vulnerability to climate-related disasters. Furthermore, the loss of forest cover and biodiversity further exacerbates the challenges faced by women, particularly in rural areas where they depend heavily on natural resources for their livelihoods,” added Dr Kamwendo.

Her participation highlights academia's crucial role in fostering inclusive and sustainable development, emphasising interdisciplinary collaboration to tackle complex environmental challenges. Through initiatives such as AFR100, stakeholders are working towards a more resilient and gender-responsive future for Africa.

News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk.
Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept